Lexeo Therapeutics, Inc. Common Stock

LXEO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$35,014$121,466$77,335$135,860
Short-Term Investments$86,504$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$4,603$2,828$2,713$824
Total Curr. Assets$126,121$124,294$80,048$136,684
Property Plant & Equip (Net)$10,557$12,261$13,775$174
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$7,012$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$3,252$3,252$7,485$2
Total NC Assets$20,821$15,513$21,260$176
Other Assets$0$0-$4,232$0
Total Assets$146,942$139,807$97,076$136,860
Liabilities
Payables$6,417$3,794$2,678$3,061
Short-Term Debt$2,670$2,605$2,834$0
Tax Payable$0$157$506$528
Deferred Revenue$0$0$0$46
Other Curr. Liab.$13,759$10,683$8,331$3,814
Total Curr. Liab.$22,846$17,239$14,349$7,449
LT Debt$7,254$9,033$10,648$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$185,033$185,013
Total NC Liab.$7,254$9,033$195,681$185,013
Other Liabilities$0$0$0$0
Cap. Leases$7,254$11,638$13,482$0
Total Liabilities$30,100$26,272$210,030$192,462
Equity
Pref Stock$0$0$0$185,013
Common Stock$3$3$0$2
Retained Earnings-$280,173-$181,840-$115,446-$56,170
AOCI-$103$0-$185,033-$185,013
Other Equity$397,115$295,372$187,525$566
Total Equity$116,842$113,535-$112,954-$55,602
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$146,942$139,807$97,076$136,860
Net Debt-$25,090-$109,828-$63,853-$135,860